Ambit Health Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Osteoboost is an FDA-cleared, drug-free prescription device that delivers precision vibration therapy to slow bone loss in postmenopausal women with osteopenia.
BiotechFemTechHealthtechMedical DevicesRedwood City, US
Daniel Burnett(Executive Officer, Director)Michael Jaasma(Director)John Osborne(Director)
Board seatSam Goldberger· per SEC Form D
Co-investorsBand of AngelsHouston Angel NetworkIT-Farm CorporationPortfoliaReno Seed FundGolden Seeds
BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms.
AI & Machine LearningBiotechDigital HealthMedical DevicesHouston, US
Steve Wallace(Chief Operating Officer, Global Supply Chain Management)Donna J. Edmonds(CEO)inJames V. Snider(Chief Technology Officer / Advisor)Tim Van Meter(Chief Scientific Officer)Richard Noel(Chief Product and Commercial Officer)Robert Sledd(Director)
Co-investorsBioventures InvestorsGenoa VenturesVTC VenturesGENERAL INCEPTION
Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status.
BiotechHealthtechMedical DevicesDanbury, US
Sasha H. Bakhru(Founder, President & CEO)Sasha Bakhru(Founder)inSolomon Steiner(Director)Michelle Brennan(Director)Daryl Mootoo(Executive Officer)Bakhru Sasha(Executive Officer, Director)
Co-investorsConnecticut Innovations
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.